We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
Change my preferences
I'm OK with analytics cookies
This document sets out some key information to help general practices and pharmacies to plan for the 2018-19 flu vaccination season, and in particular to answer patient queries about the adjuvanted trivalent flu vaccine (aTIV).